Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Reachall Pharmaceutical Co., Ltd. is a specialized Chinese pharmaceutical manufacturer and a key subsidiary of Zhejiang Huahai Pharmaceutical. Based in Linhai, Zhejiang, the company focuses on the research, development, and large-scale production of high-quality Active Pharmaceutical Ingredients (APIs) and advanced chemical intermediates. Its product portfolio primarily serves therapeutic areas such as cardiovascular health, central nervous system disorders, and antiviral treatments. Reachall operates state-of-the-art facilities that maintain rigorous international quality standards, including certifications from the US FDA and European regulatory agencies. As a critical component of the Huahai group, the company provides essential materials for both global generic drug markets and contract manufacturing partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Reachall Pharmaceutical.